A Letter to our Community: Women’s Health in Today’s America

Amboy Street Ventures is excited to announce its latest investment in Alloy Women’s Health, a digital health company committed to providing women the care they need through menopause and beyond.

In this blog, we unpack prenatal genetic screening company, BillionToOne's $130 million Series D raise to showcase the increasing number of women’s health companies reaching unicorn status. We are seeing women’s health companies close considerable growth rounds while early-stage funding remains robust.

This week we explore a major acquisition in a segment of women’s health that is often stigmatized yet universally experienced by women at some point in their lifetime: urinary incontinence.

Today, our collective work in women’s health is more critical than ever. The recent election outcome presents potential policy shifts that could reshape key areas of women’s healthcare. While these changes may bring new challenges, they also underscore why our mission—and each of yours—is vital to protecting and building the future of women’s health.

This week, we dive into Maven Clinic's recent $125 million Series F funding round and explore how this milestone sets the stage for a new era of innovation in women's and family health.

In our first blog of the Top 10 Deals of 2024 series, we showcase the acquisition of The HoneyPot Company by Compass Diversified.

Amboy Street Ventures is thrilled to announce its investment in Testmate, an at-home diagnostic test for STIs (gonorrhea, chlamydia) with immediate results.

Amboy Street Ventures is excited to announce its latest investment in Playground, Christina Aguilera’s sexual wellness company.

As the ARPA-H Sprint for Women’s Health grant proposals are due on Monday, April 15th, this week NIH Scientific Reviewer, Carolyn Kreuzkamp, gives advice on how to have a successful proposal.